Updates and advances in pyruvate kinase deficiency
Trends in Molecular Medicine · 2023
DOI: 10.1016/j.molmed.2023.02.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Molecular Medicine, 2023. Verfasst von Neeti Luke und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Hematology-Oncology, Hassenfeld Children's Hospital at NYU Langone Health, NYU Grossman School of Med…. Hauptthemen laut MEDLINE: Anemia, Hemolytic, Congenital Nonspherocytic, Pyruvate Metabolism, Inborn Errors. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Novartis, National Institutes of Health.
Abstract (Originalsprache)
Mutations in the PKLR gene lead to pyruvate kinase (PK) deficiency, causing chronic hemolytic anemia secondary to reduced red cell energy, which is crucial for maintenance of the red cell membrane and function. Heterogeneous clinical manifestations can result in significant morbidity and reduced health-related quality of life. Treatment options have historically been limited to supportive care, including red cell transfusions and splenectomy. Current disease-modifying treatment considerations include an oral allosteric PK activator, mitapivat, which was recently approved for adults with PK deficiency, and gene therapy, which is currently undergoing clinical trials. Studies evaluating the role of PK activators in other congenital hemolytic anemias are ongoing. The long-term effect of treatment with disease-modifying therapy in PK deficiency will require continued evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Pediatric Hematology-Oncology, Hassenfeld Children's Hospital at NYU Langone Health, NYU Grossman School of Medicine, New York, NY, USA.
- Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA. Electronic address: Rachael.Grace@childrens.harvard.edu.
Förderung
- NHLBI NIH HHS
- Novartis
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- American Society of Hematology
Zitieren
APA
Luke, N., Hillier, K., Al-Samkari, H., & Grace, R. F. (2023). Updates and advances in pyruvate kinase deficiency. Trends in Molecular Medicine. https://doi.org/10.1016/j.molmed.2023.02.005
Vancouver
Luke N, Hillier K, Al-Samkari H, Grace RF. Updates and advances in pyruvate kinase deficiency. Trends in Molecular Medicine. 2023. doi:10.1016/j.molmed.2023.02.005
BibTeX
@article{Luke2023,
author = {Luke, Neeti and Hillier, Kirsty and Al-Samkari, Hanny and Grace, Rachael F},
title = {Updates and advances in pyruvate kinase deficiency},
journal = {Trends in Molecular Medicine},
year = {2023},
doi = {10.1016/j.molmed.2023.02.005}
}
EUVIMED